Journal Impact Factor
MOLECULAR THERAPY NUCLEIC ACIDS Impact Score 2026
The latest ranking of MOLECULAR THERAPY NUCLEIC ACIDS has been released. Through this web page, researchers can check the ranking, journal quartile, and journal aim & scope.
MOLECULAR THERAPY NUCLEIC ACIDS: Aim & Scope
MOLECULAR THERAPY NUCLEIC ACIDS is a indexed journal tha publishes research in the area: Biochemistry, Genetics and Molecular Biology; Pharmacology, Toxicology and Pharmaceutics.
The ISSN of this journal is 21622531.
Impact Score of MOLECULAR THERAPY NUCLEIC ACIDS
| Journal Title | Molecular Therapy Nucleic Acids |
| Impact Score | 10.8 |
| SJR | 2.068 |
| ISSN | 21622531 |
| Quartile | Q1 |
Similiar journals to publish
ISSN: 2162-2531
Journal Impact: Journal Scope: Medicine: Therapeutics. Pharmacology
ISSN: 21622531
Journal Impact: Journal Scope: Drug Discovery (Q1); Molecular Medicine (Q1)
ISSN: 2162-2531
Journal Impact: 6.5
Journal Scope: Medicine, Research & Experimental
ISSN: 2162-2531
Journal Impact: Journal Scope: ISSN: 2090-021X
Journal Impact: 1.3
Journal Scope: Biochemistry & Molecular Biology
ISSN: 1362-4962
Journal Impact: 16.6
Journal Scope: Biochemistry & Molecular Biology
ISSN: 15322335
Journal Impact: Journal Scope: Medicine (miscellaneous) (Q3); Biochemistry (Q4); Genetics (Q4); Molecular Medicine (Q4)
ISSN: 1532-2335
Journal Impact: 1.1
Journal Scope: Biochemistry & Molecular Biology
ISSN: 2159-3345
Journal Impact: 4
Journal Scope: Biochemistry & Molecular Biology | Chemistry, Medicinal | Medicine, Research & Experimental
ISSN: 19349270, 19349289
Journal Impact: Journal Scope: Medicine (miscellaneous) (Q3); Biochemistry (Q4); Organic Chemistry (Q4)